PRESS & NEWS
CurePSP Ask the Doctor: March 31, 2021
Lawrence Golbe, M.D., a leading clinical expert in progressive supranuclear palsy (PSP) and related neurodegenerative conditions, will answer questions submitted by patients and families during a CurePSP Ask the Doctor webinar on Wednesday, March 31, 2021. This one-hour question-and-answer event begins at 2:00 p.m. Eastern Time (11:00 a.m. Pacific). During the webinar, Dr. Golbe will…
Lawrence Golbe, M.D., a leading clinical expert in progressive supranuclear palsy (PSP) and related neurodegenerative conditions, will answer questions submitted by patients and families during a CurePSP Ask the Doctor webinar on Wednesday, March 31, 2021. This one-hour question-and-answer event begins at 2:00 p.m. Eastern Time (11:00 a.m. Pacific).
During the webinar, Dr. Golbe will answer questions about PSP, corticobasal degeneration (CBD), and multiple system atrophy (MSA). Questions may be submitted prior to the start of the event either through the registration link or by sending an email to info@curepsp.org.
Watch the recorded webinar below.
About Dr. Larry I. Golbe
Dr. Golbe serves as Emeritus Professor of Neurology at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ. He graduated from Brown University and New York University School of Medicine and did residency training at NYU/Bellevue before assuming his current position. He was Acting Chair of the department from 2000 to 2003 and Program Director of its neurology residency from 2003 to 2018.
His research is in the clinical genetics, clinimetrics, and epidemiology of parkinsonian disorders. In 1988 he co-led the first studies of the prevalence and risk factors in PSP. He led the clinical portion of the project that in 1997 identified the first known Mendelian mutation causing Parkinson’s disease in the gene for alpha-synuclein. He devised the PSP Rating Scale, which since its publication in 2007 has become the standard clinical measure and treatment outcome marker for PSP worldwide.
He has a referral practice for patients with PSP and CBD and conducts multiple ongoing research studies and is the author of "A Clinician’s Guide to Progressive Supranuclear Palsy." He has worked closely with CurePSP since 1992, presently as Director of Clinical Affairs, chair of its Medical Advisory Board, and a member of its Board of Directors.
His hobbies include cooking, learning Italian, reading history, and leading a nonprofit devoted to academics at his high school alma mater in Englewood, N.J.
About CurePSP
CurePSP is a nonprofit organization working to increase awareness, advocate for patients and families, and fund research for devastating prime-of-life neurodegenerative diseases, including PSP, CBD, and MSA. CurePSP provides advocacy and support for patients, families, and caregivers; education for physicians and allied healthcare professionals; and funding for research.
Together we can find a cure for ftd
The FTD Disorders Registry is a powerful tool in the movement to create therapies and find a cure. Together we can help change the course of the disease and put an end to FTD.
Your privacy is important! We promise to protect it. We will not share your contact information.